CAL
APLT

Capital Advisors Ltd’s Applied Therapeutics APLT Stock Holding History

Capital Advisors Ltd’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,367
Closed -$1K – 1335
2025
Q3 		$1K Hold
2,367
– – ﹤0.01% 1132
2025
Q2 		$1K Buy
2,367
+528
+29% +$204 ﹤0.01% 1132
2025
Q1 		$1K Buy
+1,839
New +$1.08K ﹤0.01% 1117

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital Advisors Ltd's APLT Position: Q4 2025 in Review

Capital Advisors Ltd sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 2,367 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in APLT in Q1 2025 and held it in 3 quarters. The position peaked at $1K in Q3 2025. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

  • Capital Advisors Ltd reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Capital Advisors Ltd sold 2,367 Applied Therapeutics shares in Q4 2025, an estimated $1K.
  • Capital Advisors Ltd first reported a position in Applied Therapeutics in Q1 2025 and held it in 3 quarters.
  • Capital Advisors Ltd's Applied Therapeutics position peaked at $1K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on Capital Advisors Ltd's 13F filing for Q4 2025, filed 21 Jan 2026.